APA (7th ed.) Citation

johnson, s., Jegede, C. B., Gutierrez, S., Greco, S., Cummings, J., Gottlieb, K. A., & Tucker, S. N. (2023). Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: A phase 2 clinical trial. The Journal of immunology (1950), 210(1_Supplement), 246-246.09. https://doi.org/10.4049/jimmunol.210.Supp.246.09

Chicago Style (17th ed.) Citation

johnson, susan, Clara B. Jegede, Samanta Gutierrez, Susan Greco, James Cummings, Keith A. Gottlieb, and Sean N. Tucker. "Oral Tablet Vaccination Against SARS-CoV-2 Spike Boosts Cross-reactive Serum and Mucosal Neutralizing Antibodies Following MRNA Vaccination: A Phase 2 Clinical Trial." The Journal of Immunology (1950) 210, no. 1_Supplement (2023): 246-246.09. https://doi.org/10.4049/jimmunol.210.Supp.246.09.

MLA (9th ed.) Citation

johnson, susan, et al. "Oral Tablet Vaccination Against SARS-CoV-2 Spike Boosts Cross-reactive Serum and Mucosal Neutralizing Antibodies Following MRNA Vaccination: A Phase 2 Clinical Trial." The Journal of Immunology (1950), vol. 210, no. 1_Supplement, 2023, pp. 246-246.09, https://doi.org/10.4049/jimmunol.210.Supp.246.09.